Medication info
Rivaroxaban High Tablet 2/80/5 mg (Pitavastatin Calcium Hydrate, Valsartan, Amlodipine Besilate)

Rivaroxaban High Tablet 2/80/5 mg (Pitavastatin Calcium Hydrate, Valsartan, Amlodipine Besilate)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tabletPitavastatin Calcium Hydrate›2.205mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
Light purple round film-coated tablet
Packaging
30 tablets/PTP [6 tablets/PTP x 5]
Approval status
Active

MFDS item code 202502533 · Approved 2025.09.24 · Insurance code 644915460

Summary

Main use
Treatment of primary hypercholesterolemia, mixed dyslipidemia, and essential hypertension
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water. It is recommended that the medicine be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and pitavastatin. Patients taking the amlodipine/valsartan combination and pitavastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, a direct switch to the amlodipine/valsartan combination may be considered if blood pressure is not controlled with monotherapy using either component, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose. ▷ Pitavastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Treatment of primary hypercholesterolemia, mixed dyslipidemia, and essential hypertension

  • Essential hypertension
  • primary hypercholesterolemia
  • dyslipidemia
View approved original text

This medication is a combination designed for patients with essential hypertension who do not achieve adequate blood pressure control even with amlodipine and valsartan used together, as well as for patients with primary hypercholesterolemia or mixed dyslipidemia. In other words, it is a medication used for patients who have difficulty controlling blood pressure and those who need to improve cholesterol levels. Amlodipine and valsartan work to lower blood pressure and maintain vascular health, while pitavastatin reduces bad cholesterol (LDL) and triglyceride levels and increases good cholesterol (HDL), improving blood lipid balance. This medication helps to manage hypertension and dyslipidemia together, reducing the risk of cardiovascular diseases. Thus, it is effectively used for patients who have both hypertension and cholesterol problems.

How to take

Adult dose

Take 1 tablet once daily with water. It is recommended that the medicine be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and pitavastatin. Patients taking the amlodipine/valsartan combination and pitavastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, a direct switch to the amlodipine/valsartan combination may be considered if blood pressure is not controlled with monotherapy using either component, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose. ▷ Pitavastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is inadequate, the dose may be increased to a maximum of 4 mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient's response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, and use should be discontinued immediately if pregnancy is confirmed. Patients with allergies to this medication or similar drugs, pregnant or breastfeeding women, or those with severe liver or kidney dysfunction should not take this medication. Patients with sodium or fluid depletion, hyperkalemia, renal artery stenosis, or those who have recently undergone kidney transplantation should use this medication with caution under close observation by a physician. Patients with heart conditions such as heart failure, post-myocardial infarction, acute myocardial infarction, and severe aortic stenosis should also use it cautiously. This medication lowers blood pressure, so caution is needed for patients with hypotension, the elderly, and those before surgery. While taking this medication, side effects like headache, dizziness, edema, muscle pain, dyspepsia, and liver function abnormalities may occur, and patients should consult a physician immediately if they experience abnormal symptoms. Because dizziness or fatigue may occur while driving or operating machinery, caution is advised. This medication may interact with other drugs, so notify the physician or pharmacist if taking other medications. Women who are pregnant or planning to become pregnant, as well as those who are breastfeeding, should not take this medication, and use should be discontinued if pregnancy is confirmed during treatment. Safety for pediatric use has not been established, so it is advised not to use this medication in children under 18 years old. The elderly may respond more sensitively to this medication, so it is advisable to start with a lower dose and gradually increase it. Overdose may pose risks of severe hypotension and shock, so adhere to the prescribed dosage, and if an overdose occurs, visit a medical facility immediately. Store this medication out of reach of children and retain it in its original container to maintain quality.

Side effects

COVID-19, nasopharyngitis, generalized edema, peripheral edema, increased blood creatine phosphokinase activity, headache, itching, sudden sensorineural hearing loss, intestinal stricture, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste abnormalities, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, shortness of breath, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, decreased hemoglobin, decreased hematocrit, neutropenia, serum sickness, increased serum potassium, angioedema, bullous dermatitis, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, abdominal pain, rash, paralysis, increased γ-GT, elevated plasma creatine phosphokinase levels, elevated serum ALT, elevated serum AST, rhabdomyolysis, myopathy, hepatic dysfunction, jaundice, thrombocytopenia, urticaria, rash, erythema, angioedema, elevated bilirubin, increased cholinesterase, rigidity, drowsiness, heaviness of the head, dizziness, dry mouth, abdominal distension, constipation, stomatitis, loss of appetite, glossitis, nausea, gastric discomfort, diarrhea, reduced granulocytes, leukocytosis, increased globulins, positive Coombs test, anemia, polyuria, increased BUN, decreased aldosterone, increased aldosterone, increased ACTH, increased cortisol, decreased testosterone, muscle cramps, increased serum myoglobin, palpitations, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, urine hematuria, elevated uric acid levels, increased serum potassium and phosphorus, taste abnormalities, discolored urine, chronic fatigue, positive ANA, hair loss, sleep disturbances, memory loss, depression, interstitial lung disease, sexual dysfunction, immune-mediated necrotizing myopathy, facial edema, arm edema, hypersensitivity, skin paresthesia, increased blood pressure, chest discomfort, weakness, loss of appetite, thrombocytopenia, increased serum creatinine

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored at room temperature between 1 to 30 degrees Celsius, and it is important to keep it in a tightly sealed container to prevent air and moisture from entering.

Appearance and packaging

Appearance

Light purple round film-coated tablet

Package unit

30 tablets/PTP [6 tablets/PTP x 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.